Descrizione

Oral microbiota composition changes during IBS symptom exacerbation are displayed, comparing salivary and dental plaque microbial communities. Alterations in oral microbial diversity parallel gastrointestinal symptom severity.

Figure 3

Chart

Source Paper

Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.

Journal of gastroenterology (2022)

PMID: 35908139

DOI: 10.1007/s00535-022-01888-2

Cite This Figure

![Figure 3: Oral microbiota composition changes during IBS symptom exacerbation are displayed, comparing salivary and dental plaque microbial communities. Alterations in oral microbial diversity parallel gastrointestinal symptom severity.]()

> Source: Yukari Tanaka et al. "Omics profiles of fecal and oral microbiota change in irritable bowel syndrome p." *Journal of gastroenterology*, 2022. PMID: [35908139](https://pubmed.ncbi.nlm.nih.gov/35908139/)

<figure>
  <img src="" alt="Oral microbiota composition changes during IBS symptom exacerbation are displayed, comparing salivary and dental plaque microbial communities. Alterations in oral microbial diversity parallel gastrointestinal symptom severity." />
  <figcaption>Figure 3. Oral microbiota composition changes during IBS symptom exacerbation are displayed, comparing salivary and dental plaque microbial communities. Alterations in oral microbial diversity parallel gastrointestinal symptom severity.<br>  Source: Yukari Tanaka et al. "Omics profiles of fecal and oral microbiota change in irritable bowel syndrome p." <em>Journal of gastroenterology</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35908139/">35908139</a></figcaption>
</figure>

Evidenze correlate

L-Glutamine per Irritable Bowel Syndrome (IBS)

Grado C · 2 studi